Scientists might not be able to build a Bionic Woman just yet, but there’s a healthy market for the spare hips, knees and joints that are in demand thanks to a growing baby-boomer population. Of all the medical-device makers in this space, Cramer said likes Stryker the best.
The stock has been under pressure because of payola charges by the Department of Justice. Basically, Stryker and four other companies were charged with paying doctors to use their products. But since a settlement was announced a week ago, the share price is up about five points.